tiprankstipranks
Trending News
More News >
Callan JMB, Inc. (CJMB)
NASDAQ:CJMB
US Market
Advertisement

Callan JMB, Inc. (CJMB) AI Stock Analysis

Compare
7 Followers

Top Page

CJMB

Callan JMB, Inc.

(NASDAQ:CJMB)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 4o)
Rating:53Neutral
Price Target:
$5.00
▲(0.20% Upside)
The overall stock score of 53 reflects significant financial challenges, with declining revenues and profitability being the most impactful factors. Technical analysis shows mixed signals, with slight positive momentum but potential bearish indicators. The absence of valuation metrics adds uncertainty to the stock's attractiveness.

Callan JMB, Inc. (CJMB) vs. SPDR S&P 500 ETF (SPY)

Callan JMB, Inc. Business Overview & Revenue Model

Company DescriptionCallan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.
How the Company Makes MoneyCJMB generates revenue through multiple streams. Its primary revenue model is based on service contracts with businesses seeking technological solutions and consulting services. The company charges clients for software development projects, ongoing support and maintenance, and consulting fees for strategic advice. Additionally, CJMB partners with technology firms to offer integrated solutions, which can lead to revenue-sharing agreements. The company may also generate income through licensing proprietary software tools developed in-house, further diversifying its revenue sources.

Callan JMB, Inc. Financial Statement Overview

Summary
The income statement reveals significant challenges with declining revenues and profitability, although the cash flow remains positive. The balance sheet shows a stable leverage position, but weakening equity raises concerns.
Income Statement
30
Negative
The income statement reveals significant challenges, with a sharp decline in revenue and profitability. Gross profit margin has deteriorated, and the company has moved from a profitable position to reporting negative EBIT and net income. This indicates severe operational issues and declining market performance.
Balance Sheet
60
Neutral
The balance sheet remains relatively stable, with a positive equity position. However, the decrease in assets and equity raises concerns. The debt-to-equity ratio remains low, suggesting manageable leverage, yet the declining equity ratio could pose future risks.
Cash Flow
55
Neutral
Cash flows show resilience, with positive free cash flow even amidst declining revenue. Operating cash flow remains positive, suggesting effective cash management, but the significant drop from previous years highlights the need for caution in sustaining cash generation.
BreakdownDec 2024Dec 2023Dec 2022
Income Statement
Total Revenue6.56M13.20M22.77M
Gross Profit2.56M5.65M9.45M
EBITDA-2.12M2.30M6.37M
Net Income-2.29M2.18M6.22M
Balance Sheet
Total Assets5.08M9.71M15.25M
Cash, Cash Equivalents and Short-Term Investments2.10M5.16M6.19M
Total Debt907.45K400.00K410.88K
Total Liabilities1.91M910.27K1.24M
Stockholders Equity3.17M8.80M14.01M
Cash Flow
Free Cash Flow494.19K6.51M8.94M
Operating Cash Flow540.35K7.00M9.36M
Investing Cash Flow-46.17K-490.02K-422.49K
Financing Cash Flow-3.55M-7.54M-4.57M

Callan JMB, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
53
Neutral
51
Neutral
6.56M0.6725.90%22.89%-46.58%
46
Neutral
13.31M-2.20-45.24%0.00%0.00%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CJMB
Callan JMB, Inc.
4.99
-1.33
-21.04%
SGLY
Singularity Future Technology
1.39
-0.26
-15.76%
ATXG
Addentax Group
0.83
0.31
59.62%
PSIG
PS International Group
0.51
-0.35
-40.70%
GVH
Globavend Holdings Ltd.
5.16
-157.34
-96.82%
NCEW
New Century Logistics (BVI) Ltd.
0.63
-1.97
-75.77%

Callan JMB, Inc. Corporate Events

Private Placements and FinancingRegulatory Filings and Compliance
Callan JMB Enters $25M Purchase Agreement
Neutral
Jul 25, 2025

On July 24, 2025, Callan JMB Inc. entered into a Purchase Agreement with an investor, allowing the company to potentially sell up to $25 million of its common stock. The agreement provides Callan JMB with flexibility in raising capital, as it is not obligated to sell shares and can issue purchase notices based on market conditions. The company also entered a Registration Rights Agreement, requiring it to file a registration statement with the SEC. Failure to comply with these terms would result in the issuance of additional shares to the investor.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 11, 2025